Francisella tularensis as a potential agent of bioterrorism?

被引：49

作者：

Maurin, Max ^{[1
,2
,3
]}

机构：

[1] CHU Grenoble, Ctr Natl Reference Francisella, Dept Agents Infect, Inst Biol & Pathol, F-38043 Grenoble, France

[2] Univ Grenoble Alpes, LAPM, F-38000 Grenoble, France

[3] CNRS, LAPM, UMR 5163, F-38000 Grenoble, France

来源：

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2015年 / 13卷 / 02期

关键词：

biological threat; bioterrorism; category A bioterrorism agents; drug development; Francisella tularensis; new drugs; tularemia; TULAREMIA; IDENTIFICATION; CIPROFLOXACIN; RESISTANCE; DIAGNOSIS; THERAPY;

D O I：

10.1586/14787210.2015.986463

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Francisella tularensis is a category A bioterrorism agent. It is the etiological agent of tularemia, a zoonotic disease found throughout the northern hemisphere. The intentional spread of F. tularensis aerosols would probably lead to severe and often fatal pneumonia cases, but also secondary cases from contaminated animals and environments. We are not ready to face such a situation. No vaccine is currently available. A few antibiotics are active against F. tularensis, but strains resistant to these antibiotics could be used in the context of bioterrorism. We need new therapeutic strategies to fight against category A bioterrorism agents, including development of new drugs inhibiting F. tularensis growth and/or virulence, or enhancing the host response to infection by this pathogen. © 2015 Informa UK, Ltd.

引用

页码：141 / 144

页数：4

共 29 条

[1] Metabolic Network Analysis-Based Identification of Antimicrobial Drug Targets in Category A Bioterrorism Agents [J].

Ahn, Yong-Yeol ;

Lee, Deok-Sun ;

Burd, Henry ;

Blank, William ;

Kapatral, Vinayak .

PLOS ONE, 2014, 9 (01)

[2] Neutrophils: potential therapeutic targets in tularemia? [J].

Allen, Lee-Ann H. .

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2013, 3

[3] High-Throughput Screening of a Diversity Collection Using Biodefense Category A and B Priority Pathogens [J].

Barrow, Esther W. ;

Clinkenbeard, Patricia A. ;

Duncan-Decocq, Rebecca A. ;

Perteet, Rachel F. ;

Hill, Kimberly D. ;

Bourne, Philip C. ;

Valderas, Michelle W. ;

Bourne, Christina R. ;

Clarkson, Nicole L. ;

Clinkenbeard, Kenneth D. ;

Barrow, William W. .

JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (07) :946-956

[4] Francisella tularensis subsp tularensis Group A.I, United States [J].

Birdsell, Dawn N. ;

Johansson, Anders ;

Ohrman, Caroline ;

Kaufman, Emily ;

Molins, Claudia ;

Pearson, Talima ;

Gyuranecz, Miklos ;

Naumann, Amber ;

Vogler, Amy J. ;

Myrtennas, Kerstin ;

Larsson, Par ;

Forsman, Mats ;

Sjodin, Andreas ;

Gillece, John D. ;

Schupp, James ;

Petersen, Jeannine M. ;

Keim, Paul ;

Wagner, David M. .

EMERGING INFECTIOUS DISEASES, 2014, 20 (05) :861-865

[5] New therapeutic approaches for treatment of tularaemia: a review [J].

Boisset, Sandrine ;

Caspar, Yvan ;

Sutera, Vivien ;

Maurin, Max .

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2014, 4

[6] Unique Substrates Secreted by the Type VI Secretion System of Francisella tularensis during Intramacrophage Infection [J].

Broms, Jeanette E. ;

Meyer, Lena ;

Sun, Kun ;

Lavander, Moa ;

Sjostedt, Anders .

PLOS ONE, 2012, 7 (11)

[7] Bis-indolic compounds as potential new therapeutic alternatives for tularaemia [J].

Caspar, Yvan ;

Sutera, Vivien ;

Boisset, Sandrine ;

Denis, Jean-Neol ;

Maurin, Max .

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2014, 4

[8] Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction [J].

Chaudhury, Sidhartha ;

Abdulhameed, Mohamed Diwan M. ;

Singh, Narender ;

Tawa, Gregory J. ;

D'haeseleer, Patrik M. ;

Zemla, Adam T. ;

Navid, Ali ;

Zhou, Carol E. ;

Franklin, Matthew C. ;

Cheung, Jonah ;

Rudolph, Michael J. ;

Love, James ;

Graf, John F. ;

Rozak, David A. ;

Dankmeyer, Jennifer L. ;

Amemiya, Kei ;

Daefler, Simon ;

Wallqvist, Anders .

PLOS ONE, 2013, 8 (05)

[9]

Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]

[10] Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice [J].

Flick-Smith, Helen C. ;

Fox, Marc A. ;

Hamblin, Karleigh A. ;

Richards, Mark I. ;

Jenner, Dominic C. ;

Laws, Thomas R. ;

Phelps, Amanda L. ;

Taylor, Christopher ;

Harding, Sarah V. ;

Ulaeto, David O. ;

Atkins, Helen S. .

PEPTIDES, 2013, 43 :96-101

← 1 2 3 →